The atrial fibrillation market was estimated to be worth USD 6 billion in 2012. It is likely to rise during the projected phase, at around 13 percent CAGR. The projected phase continues from 2013 to 2019. This market is anticipated to reach USD 15 billion by the end of the phase.
Atrial fibrillation is a type of cardiac arrhythmia and is recognized by anomalous heart rhythm. This rhythm arises due to issues in the heart’s electrical system. The atrial fibrillation market is driven further by cases of brain damage, strokes and atrial fibrillation.
North America accounted for the biggest share in the atrial fibrillation market in 2013.